drugset / Trial / NCT03156920

Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers

NCT03156920

Completed 30 enrolled Danish Headache Center
RandomizedCrossoverDouble-blindTreatment

Summary

To develop a pragmatic migraine model the investigators will induce headache in healthy volunteers with a phosphodiesterase inhibitor (cilostazol). The participants will be pre-treated with sumatriptan. If the headache responds to sumatriptan, the model can be used to test new drug candidates.

Timeline

Start
2017-05-23
Primary completion
2017-10-18
Completion
2017-10-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sumatriptan Unknown 100 mg Oral

Indications